Press Releases

"[B]ipartisan cooperation has been the exception, rather than the rule. Under your leadership, bipartisan solutions to real problems affecting real Americans have been sacrificed in favor of Committee Democrats’ obsession with impeaching the president and undoing the 2016 election."

"We do not have the Schiff Report. We do not have any underlying materials to the Schiff Report. We do not know of any hearings other than one of academics and possibly a presentation by Chairman Schiff’s committee. For the first time in history, this Committee will weigh impeachment without any evidence for us to review." 

"The Committee must ensure it maintains its credibility and its historically preeminent role in the impeachment of presidents by not rushing to articles of impeachment or hearing only from scholars with demonstrated animosity towards the President. Throughout this hurried and partisan impeachment process, I have consistently requested mere fairness from members of the majority. An equal distribution of experts for the December 4 hearing would be a small concession to demonstrate to the American people this impeachment inquiry is not merely political theater." 

"Chairman Schiff has engaged in an assault on the already one-sided process. Based on the publicly available transcripts, it appears Chairman Schiff has worked in concert with select disgruntled bureaucrats to withhold evidence from Intelligence Committee Republicans, this Committee, and the American people.""In light of how Chairman Schiff is conducting the impeachment process and pursuant to Section III of H. Res. 660, all materials in the custody of the Intelligence Committee should be transmitted immediately to this Committee..."

"In spite of how important this issue is to consumers and businesses, this committee dragged its feet, and, instead, fixated on going after President Trump in an attempt to undo the 2016 election. That nonsense is now taking place in other committees rather than our own. 

"Everyone knows that I believe in a strong patent system — that it’s essential to our economy, creating jobs and keeping America the world’s technology leader. Patents may be most important to the pharmaceutical and biologic industries. Without patents, companies cannot justify the tremendous investment needed to develop and bring to market the life-saving and life-improving innovations American companies offer patients in this country each year."

"The Affordable Prescriptions for Patients Through Promoting Competition Act of 2019 strikes a good balance by giving the FTC the clear authority to prosecute cases in which a company has engaged in product hopping, without disincentivizing innovation to improve patient care. 

"Growers are increasingly turning to the H-2A visa program to get the temporary labor they need, but the program needs reform. The agricultural industry wants and deserves a streamlined program that provides more certainty as to the temporary labor needed to sustain their businesses.

"H-2A users have asked Congress for many reforms of the H-2A program. Unfortunately, despite its proponents’ claims, H.R. 5038 doesn’t fix many of the issues with the program, and, in some cases, the bill makes the problems worse."